caffeine and regadenoson

caffeine has been researched along with regadenoson in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (15.38)29.6817
2010's10 (76.92)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
de Lera Ruiz, M; Lim, YH; Zheng, J1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Belardinelli, L; Hintze, TH; Leung, K; Messina, E; Ochoa, M; Shryock, J; Sun, HL; Xu, X; Zhao, G1
Fleischman, S; Gaemperli, O; Kaufmann, PA; Koepfli, P; Lieu, H; Nguyen, P; Olmsted, A; Schepis, T; Siegrist, PT; Wang, W1
Abbott, BG; Gemignani, AS1
Franks, B; Iskandrian, AE; McNutt, BE; Tejani, FH; Thompson, RC1
Bukofzer, S; Kristy, R; Tejani, FH; Thompson, RC1
Bitar, A; Kreutz, RP; Mastouri, R1
Doran, JA; Gupta, R; Mackin, ML; Sajjad, W; Schneider, MD; Schwartz, RG1
Jolly, AF; Thomas, GS1
Kaandorp, TAM; Kuijpers, D; Oudkerk, M; van der Harst, P; van Dijk, R; van Dijkman, PRM; Vliegenthart, R1
Babar, AK; Bui, L; DeGolovine, A; Gould, KL; Johnson, NP; Kitkungvan, D; Kumar, S; Madjid, M; Nacimbene, A; Patel, MB; Roby, AE; Vejpongsa, P1
Abidov, A; Harhash, AA; Huang, JJ; Kay, MD; Krupinski, EA; Kuo, PH; McMillan, NA; Posch, MI1

Reviews

3 review(s) available for caffeine and regadenoson

ArticleYear
Adenosine A2A receptor as a drug discovery target.
    Journal of medicinal chemistry, 2014, May-08, Volume: 57, Issue:9

    Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Protein Conformation; Receptor, Adenosine A2A; Signal Transduction

2014
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
The emerging role of the selective A2A agonist in pharmacologic stress testing.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2010, Volume: 17, Issue:3

    Topics: Animals; Caffeine; Exercise; Humans; Myocardial Perfusion Imaging; Purines; Pyrazoles; Receptor, Adenosine A2A; Vasodilation

2010

Trials

5 trial(s) available for caffeine and regadenoson

ArticleYear
Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial.
    Journal of the American College of Cardiology, 2008, Jan-22, Volume: 51, Issue:3

    Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Caffeine; Coronary Circulation; Cross-Over Studies; Double-Blind Method; Drug Interactions; Heart Rate; Humans; Positron-Emission Tomography; Purines; Pyrazoles; Vasodilator Agents

2008
Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: rationale and design of a prospective, randomized, multicenter study.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2011, Volume: 18, Issue:1

    Topics: Adenosine A2 Receptor Antagonists; Administration, Oral; Adult; Aged; Aged, 80 and over; Caffeine; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Central Nervous System Stimulants; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Interactions; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Prevalence; Prospective Studies; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; United States; Young Adult

2011
Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study.
    The international journal of cardiovascular imaging, 2014, Volume: 30, Issue:5

    Topics: Adenosine A2 Receptor Agonists; Adult; Aged; Aged, 80 and over; Caffeine; Coronary Disease; Double-Blind Method; Exercise Test; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Prospective Studies; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon

2014
Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:3

    Topics: Administration, Oral; Aged; Aminophylline; Caffeine; Cardiotonic Agents; Causality; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Exercise Test; Female; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Myocardial Perfusion Imaging; New York; Purines; Pyrazoles; Survival Rate; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vasodilator Agents

2017
Quantitative myocardial perfusion positron emission tomography and caffeine revisited with new insights on major adverse cardiovascular events and coronary flow capacity.
    European heart journal. Cardiovascular Imaging, 2019, Jul-01, Volume: 20, Issue:7

    Topics: Adenosine; Adenosine A2 Receptor Agonists; Aged; Caffeine; Cardiovascular Diseases; Coronary Circulation; Dipyridamole; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Pyrazoles

2019

Other Studies

5 other study(ies) available for caffeine and regadenoson

ArticleYear
Caffeine attenuates the duration of coronary vasodilation and changes in hemodynamics induced by regadenoson (CVT-3146), a novel adenosine A2A receptor agonist.
    Journal of cardiovascular pharmacology, 2007, Volume: 49, Issue:6

    Topics: Adenosine A2 Receptor Agonists; Animals; Blood Pressure; Caffeine; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Male; Purines; Pyrazoles; Time Factors; Vasodilation

2007
Caffeine Consumption and Heart Rate and Blood Pressure Response to Regadenoson.
    PloS one, 2015, Volume: 10, Issue:6

    Topics: Blood Pressure; Caffeine; Coffee; Female; Habits; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Purines; Pyrazoles; Systole

2015
Intravenous caffeine: An alternative to aminophylline to reverse adverse effects during regadenoson myocardial perfusion imaging.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:3

    Topics: Aminophylline; Caffeine; Exercise Test; Myocardial Perfusion Imaging; Purines; Pyrazoles; Vasodilator Agents

2017
Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping.
    The international journal of cardiovascular imaging, 2017, Volume: 33, Issue:11

    Topics: Adenosine; Aged; Caffeine; Coffee; Coronary Artery Disease; Coronary Circulation; Female; Humans; Hyperemia; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Pyrazoles; Reproducibility of Results; Time Factors; Vasodilator Agents

2017
Daily Caffeine Consumption Is Associated with Decreased Incidence of Symptoms and Hemodynamic Changes During Pharmacologic Stress with Regadenoson.
    Journal of nuclear medicine technology, 2020, Volume: 48, Issue:1

    Topics: Adenosine A2 Receptor Agonists; Adult; Aged; Aminophylline; Arrhythmias, Cardiac; Blood Pressure; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Eating; Exercise Test; Female; Heart Rate; Hemodynamics; Humans; Incidence; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Treatment Outcome

2020